Compare GSK & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSK | SYK |
|---|---|---|
| Founded | 1715 | 1941 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.1B | 140.0B |
| IPO Year | N/A | 1994 |
| Metric | GSK | SYK |
|---|---|---|
| Price | $53.47 | $335.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | N/A | ★ $431.08 |
| AVG Volume (30 Days) | ★ 4.9M | 1.7M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 3.23% | 1.04% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 8.40 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $6.81 | $9.86 |
| Revenue Next Year | $4.74 | $8.39 |
| P/E Ratio | ★ $32.75 | $40.23 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $32.38 | $328.23 |
| 52 Week High | $61.70 | $404.87 |
| Indicator | GSK | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 37.71 | 26.59 |
| Support Level | $47.89 | N/A |
| Resistance Level | $60.37 | $375.26 |
| Average True Range (ATR) | 0.93 | 8.49 |
| MACD | -0.78 | -5.66 |
| Stochastic Oscillator | 1.31 | 12.76 |
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.